caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1659307346

Pablo TebasMD

PRACTICEUNIV OF PENN IMAGING CENTERSee all providers at this practice →
Infectious DiseasePhiladelphia, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Pablo Tebas's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Michael Riley
Clinical Cardiac Electrophysiology · Philadelphia, PA
1528
PRESBYTERIAN MEDICAL CENTER OF THE UNIVERSITY OF PENNSYLVANIA HEALTH S1430
Ana Kolansky
Diagnostic Radiology · Philadelphia, PA
1220
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
1236
Rosita Shah
Diagnostic Radiology · Philadelphia, PA
1128
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
113
Unique beneficiaries
—
Total services
179
Distinct HCPCS
6
Medicare payment
$12K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 346 Infectious Disease providers in PA — below median (cohort median 364).
PRESCRIBING · PART D · 2024
Total Rx claims
735
Beneficiaries
—
Total drug cost
$2.0M
Distinct drugs
31
Brand share
69.5%
Top prescribed drugs
Bictegrav/Emtricit/Tenofov Ala84 claims
Dolutegravir Sodium78 claims
Emtricitabine/Tenofov Alafenam48 claims
Emtricitab/Rilpiviri/Tenof Ala39 claims
Darunavir28 claims
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
73.6
Cost
76.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.42%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$40K
Payment records
41
By payment type
Consulting Fee$37K
Travel and Lodging$2K
Food and Beverage$1K